JQOClass I
Balance, Analytical
21 CFR 862.2050 / Clinical Chemistry
JQO is the FDA product code for Balance, Analytical, a class I device type, regulated under 21 CFR 862.2050. As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- JQO
- Device name
- Balance, Analytical
- Regulation
- 21 CFR 862.2050
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- Yes
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this code- Arthrex Australia Pty Ltd.
- Arthrex Colombia SAS
- Arthrex Distribution Hub EMEA B.V.
- Arthrex GmbH
- Arthrex Logistic Center
- Arthrex Manufacturing Inc.
- Arthrex New Zealand Limited
- Arthrex Singapore Pte Ltd.
- Biocells Discoveries Internacional (Biocells)
- Falcon Surgical Co. (Pvt.) Ltd.
- Heuer International (A division of GST Corporation Limited)
- Mark Enterprises
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
